8219 Biochemical Disease Severity Score For Hypercortisolism Can Predict Adrenal Insufficiency After Adrenalectomy For Mild Autonomous Cortisol Secretion
Abstract Disclosure: O. Hamidi: Advisory Board Member; Self; Corcept, Neurocrine Biosciences, Amryt Pharma, Recordati Rare Diseases, Lantheus, Xeris. B.H. Salama: None. P. Dogra: None. A.P. Dackiw: None. F. Nwariaku: None. A. Islam: None. A. Mehta: None. S.C. Oltmann: None. S. Mirfakhraee: None. T....
Gespeichert in:
| Veröffentlicht in: | Journal of the Endocrine Society 2024-10, Vol.8 (Supplement_1) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Supplement_1 |
| container_start_page | |
| container_title | Journal of the Endocrine Society |
| container_volume | 8 |
| creator | Hamidi, Oksana Salama, Bahaa H Dogra, Prerna Dackiw, Alan P B Nwariaku, Fiemu Islam, Ana Mehta, Ankeeta Catherine Oltmann, Sarah Mirfakhraee, Sasan McKenzie, Travis Foster, Trenton R Lyden, Melanie Dy, Benzon M Bancos, Irina |
| description | Abstract
Disclosure: O. Hamidi: Advisory Board Member; Self; Corcept, Neurocrine Biosciences, Amryt Pharma, Recordati Rare Diseases, Lantheus, Xeris. B.H. Salama: None. P. Dogra: None. A.P. Dackiw: None. F. Nwariaku: None. A. Islam: None. A. Mehta: None. S.C. Oltmann: None. S. Mirfakhraee: None. T. McKenzie: None. T.R. Foster: None. M. Lyden: None. B.M. Dy: None. I. Bancos: None.
Introduction: Patients with mild autonomous cortisol secretion (MACS) are at risk for adrenal insufficiency (AI) after unilateral adrenalectomy. We aimed to determine the prevalence, predictors, and duration of AI after unilateral adrenalectomy for MACS, and to compare baseline and peak cortisol post cosyntropin stimulation test (CST) in diagnosing AI. Methods: We conducted a dual-center retrospective cohort study of patients with MACS who underwent unilateral adrenalectomy and were evaluated with postoperative cosyntropin stimulation test (CST). AI was diagnosed when postoperative morning cortisol was |
| doi_str_mv | 10.1210/jendso/bvae163.124 |
| format | Article |
| fullrecord | <record><control><sourceid>oup_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11454705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/jendso/bvae163.124</oup_id><sourcerecordid>10.1210/jendso/bvae163.124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1814-50c2a29f6225596ae01bc8bef55feaf2ee3c7f0b2c5207a456d6221b290ea0473</originalsourceid><addsrcrecordid>eNqNkUFOwzAQRSMEEhX0Aqx8gVDbtZNmhUKgtFIRSIV15Dhj6iqxIzuplKNwWwIpCHasZubP_DeLHwRXBF8TSvBsD6b0dlYcBJBoPmjsJJhQFtOQJDE9_dWfB1Pv9xhjksxZwtgkeF9QkqBbbeUOai1Fhe60B-EBbeEATrc92krrAC2tQ6u-ATdMrfa20r5GmTDo2UGpZYvS0oEZ_GvjO6W01GBkj1LVgvvegWxt3X-hHnVVorRrrbG17TzKjtThrXTQamsugzMlKg_TY70IXpf3L9kq3Dw9rLN0E0qyICzkWFJBExVRynkSCcCkkIsCFOcKhKIAcxkrXFDJKY4F41E5nJKCJhgEZvH8IrgZuU1X1FBKMK0TVd44XQvX51bo_O_G6F3-Zg85IYyzGPOBQEeCdNZ7B-rHTHD-mVA-JpQfExo0NpjC0WS75j_3H4f1mns</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>8219 Biochemical Disease Severity Score For Hypercortisolism Can Predict Adrenal Insufficiency After Adrenalectomy For Mild Autonomous Cortisol Secretion</title><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hamidi, Oksana ; Salama, Bahaa H ; Dogra, Prerna ; Dackiw, Alan P B ; Nwariaku, Fiemu ; Islam, Ana ; Mehta, Ankeeta ; Catherine Oltmann, Sarah ; Mirfakhraee, Sasan ; McKenzie, Travis ; Foster, Trenton R ; Lyden, Melanie ; Dy, Benzon M ; Bancos, Irina</creator><creatorcontrib>Hamidi, Oksana ; Salama, Bahaa H ; Dogra, Prerna ; Dackiw, Alan P B ; Nwariaku, Fiemu ; Islam, Ana ; Mehta, Ankeeta ; Catherine Oltmann, Sarah ; Mirfakhraee, Sasan ; McKenzie, Travis ; Foster, Trenton R ; Lyden, Melanie ; Dy, Benzon M ; Bancos, Irina</creatorcontrib><description><![CDATA[Abstract
Disclosure: O. Hamidi: Advisory Board Member; Self; Corcept, Neurocrine Biosciences, Amryt Pharma, Recordati Rare Diseases, Lantheus, Xeris. B.H. Salama: None. P. Dogra: None. A.P. Dackiw: None. F. Nwariaku: None. A. Islam: None. A. Mehta: None. S.C. Oltmann: None. S. Mirfakhraee: None. T. McKenzie: None. T.R. Foster: None. M. Lyden: None. B.M. Dy: None. I. Bancos: None.
Introduction: Patients with mild autonomous cortisol secretion (MACS) are at risk for adrenal insufficiency (AI) after unilateral adrenalectomy. We aimed to determine the prevalence, predictors, and duration of AI after unilateral adrenalectomy for MACS, and to compare baseline and peak cortisol post cosyntropin stimulation test (CST) in diagnosing AI. Methods: We conducted a dual-center retrospective cohort study of patients with MACS who underwent unilateral adrenalectomy and were evaluated with postoperative cosyntropin stimulation test (CST). AI was diagnosed when postoperative morning cortisol was <10μg/dL and/or CST peak cortisol was <18μg/dL. Baseline and CST peak cortisol levels were considered concordant when both met corresponding cut-offs. Biochemical (BSS) and clinical (CSS) severity scores for hypercortisolism were calculated. Results: In 100 adults with MACS (77% women, median age 56 years, interquartile range [IQR] 48-63), median adenoma size was 2.8 cm (IQR, 2.2-3.7), and 25 (25%) had bilateral nodules. Median BSS was 3 (IQR, 2-5) and median CSS was 4 (IQR, 2-8). After adrenalectomy, AI was diagnosed in 56 (56%) patients. AI was associated with higher BSS, larger tumor size, but not age, sex, BMI, tumor laterality. Baseline and CST peak cortisol levels were concordant in 76% of cases. In 14% of cases morning cortisol was <10μg/dL but CST peak cortisol was ≥18μg/dL, and in 10% of cases morning cortisol was ≥10μg/dL, but CST peak cortisol was <18μg/dL. On a multivariable analysis that included age, sex, BMI, BSS, laterality, and tumor size, only higher BSS (odd ratio [OR] = 1.6 per 1 point) was associated with postoperative baseline cortisol <10μg/dL (P<0.05 for all). Independent predictors of CST peak cortisol <18μg/dL were BSS (OR 1.5 per 1 point) and unilateral adenoma (OR 3.7). During a median postoperative follow up of 13 months, 33 (59%) patients recovered from AI. Median time to recovery was 6.0 months, with AI recovery in 28% of patients by 2 months, 42% by 3 months, 53% by 6 months, and 64% by 12 months. Conclusions: Prevalence of postoperative AI in MACS was 56%. Only 76% of patients had concordant baseline and CST peak cortisol, with peak CST cortisol being more commonly abnormal in patients treated for unilateral MACS. Patients with larger adenomas and higher BSS were at higher risk for AI. Patients with MACS should be counseled about the risk and duration of AI after adrenalectomy.
Presentation: 6/3/2024]]></description><identifier>ISSN: 2472-1972</identifier><identifier>EISSN: 2472-1972</identifier><identifier>DOI: 10.1210/jendso/bvae163.124</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Abstract</subject><ispartof>Journal of the Endocrine Society, 2024-10, Vol.8 (Supplement_1)</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11454705/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11454705/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids></links><search><creatorcontrib>Hamidi, Oksana</creatorcontrib><creatorcontrib>Salama, Bahaa H</creatorcontrib><creatorcontrib>Dogra, Prerna</creatorcontrib><creatorcontrib>Dackiw, Alan P B</creatorcontrib><creatorcontrib>Nwariaku, Fiemu</creatorcontrib><creatorcontrib>Islam, Ana</creatorcontrib><creatorcontrib>Mehta, Ankeeta</creatorcontrib><creatorcontrib>Catherine Oltmann, Sarah</creatorcontrib><creatorcontrib>Mirfakhraee, Sasan</creatorcontrib><creatorcontrib>McKenzie, Travis</creatorcontrib><creatorcontrib>Foster, Trenton R</creatorcontrib><creatorcontrib>Lyden, Melanie</creatorcontrib><creatorcontrib>Dy, Benzon M</creatorcontrib><creatorcontrib>Bancos, Irina</creatorcontrib><title>8219 Biochemical Disease Severity Score For Hypercortisolism Can Predict Adrenal Insufficiency After Adrenalectomy For Mild Autonomous Cortisol Secretion</title><title>Journal of the Endocrine Society</title><description><![CDATA[Abstract
Disclosure: O. Hamidi: Advisory Board Member; Self; Corcept, Neurocrine Biosciences, Amryt Pharma, Recordati Rare Diseases, Lantheus, Xeris. B.H. Salama: None. P. Dogra: None. A.P. Dackiw: None. F. Nwariaku: None. A. Islam: None. A. Mehta: None. S.C. Oltmann: None. S. Mirfakhraee: None. T. McKenzie: None. T.R. Foster: None. M. Lyden: None. B.M. Dy: None. I. Bancos: None.
Introduction: Patients with mild autonomous cortisol secretion (MACS) are at risk for adrenal insufficiency (AI) after unilateral adrenalectomy. We aimed to determine the prevalence, predictors, and duration of AI after unilateral adrenalectomy for MACS, and to compare baseline and peak cortisol post cosyntropin stimulation test (CST) in diagnosing AI. Methods: We conducted a dual-center retrospective cohort study of patients with MACS who underwent unilateral adrenalectomy and were evaluated with postoperative cosyntropin stimulation test (CST). AI was diagnosed when postoperative morning cortisol was <10μg/dL and/or CST peak cortisol was <18μg/dL. Baseline and CST peak cortisol levels were considered concordant when both met corresponding cut-offs. Biochemical (BSS) and clinical (CSS) severity scores for hypercortisolism were calculated. Results: In 100 adults with MACS (77% women, median age 56 years, interquartile range [IQR] 48-63), median adenoma size was 2.8 cm (IQR, 2.2-3.7), and 25 (25%) had bilateral nodules. Median BSS was 3 (IQR, 2-5) and median CSS was 4 (IQR, 2-8). After adrenalectomy, AI was diagnosed in 56 (56%) patients. AI was associated with higher BSS, larger tumor size, but not age, sex, BMI, tumor laterality. Baseline and CST peak cortisol levels were concordant in 76% of cases. In 14% of cases morning cortisol was <10μg/dL but CST peak cortisol was ≥18μg/dL, and in 10% of cases morning cortisol was ≥10μg/dL, but CST peak cortisol was <18μg/dL. On a multivariable analysis that included age, sex, BMI, BSS, laterality, and tumor size, only higher BSS (odd ratio [OR] = 1.6 per 1 point) was associated with postoperative baseline cortisol <10μg/dL (P<0.05 for all). Independent predictors of CST peak cortisol <18μg/dL were BSS (OR 1.5 per 1 point) and unilateral adenoma (OR 3.7). During a median postoperative follow up of 13 months, 33 (59%) patients recovered from AI. Median time to recovery was 6.0 months, with AI recovery in 28% of patients by 2 months, 42% by 3 months, 53% by 6 months, and 64% by 12 months. Conclusions: Prevalence of postoperative AI in MACS was 56%. Only 76% of patients had concordant baseline and CST peak cortisol, with peak CST cortisol being more commonly abnormal in patients treated for unilateral MACS. Patients with larger adenomas and higher BSS were at higher risk for AI. Patients with MACS should be counseled about the risk and duration of AI after adrenalectomy.
Presentation: 6/3/2024]]></description><subject>Abstract</subject><issn>2472-1972</issn><issn>2472-1972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqNkUFOwzAQRSMEEhX0Aqx8gVDbtZNmhUKgtFIRSIV15Dhj6iqxIzuplKNwWwIpCHasZubP_DeLHwRXBF8TSvBsD6b0dlYcBJBoPmjsJJhQFtOQJDE9_dWfB1Pv9xhjksxZwtgkeF9QkqBbbeUOai1Fhe60B-EBbeEATrc92krrAC2tQ6u-ATdMrfa20r5GmTDo2UGpZYvS0oEZ_GvjO6W01GBkj1LVgvvegWxt3X-hHnVVorRrrbG17TzKjtThrXTQamsugzMlKg_TY70IXpf3L9kq3Dw9rLN0E0qyICzkWFJBExVRynkSCcCkkIsCFOcKhKIAcxkrXFDJKY4F41E5nJKCJhgEZvH8IrgZuU1X1FBKMK0TVd44XQvX51bo_O_G6F3-Zg85IYyzGPOBQEeCdNZ7B-rHTHD-mVA-JpQfExo0NpjC0WS75j_3H4f1mns</recordid><startdate>20241005</startdate><enddate>20241005</enddate><creator>Hamidi, Oksana</creator><creator>Salama, Bahaa H</creator><creator>Dogra, Prerna</creator><creator>Dackiw, Alan P B</creator><creator>Nwariaku, Fiemu</creator><creator>Islam, Ana</creator><creator>Mehta, Ankeeta</creator><creator>Catherine Oltmann, Sarah</creator><creator>Mirfakhraee, Sasan</creator><creator>McKenzie, Travis</creator><creator>Foster, Trenton R</creator><creator>Lyden, Melanie</creator><creator>Dy, Benzon M</creator><creator>Bancos, Irina</creator><general>Oxford University Press</general><scope>TOX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20241005</creationdate><title>8219 Biochemical Disease Severity Score For Hypercortisolism Can Predict Adrenal Insufficiency After Adrenalectomy For Mild Autonomous Cortisol Secretion</title><author>Hamidi, Oksana ; Salama, Bahaa H ; Dogra, Prerna ; Dackiw, Alan P B ; Nwariaku, Fiemu ; Islam, Ana ; Mehta, Ankeeta ; Catherine Oltmann, Sarah ; Mirfakhraee, Sasan ; McKenzie, Travis ; Foster, Trenton R ; Lyden, Melanie ; Dy, Benzon M ; Bancos, Irina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1814-50c2a29f6225596ae01bc8bef55feaf2ee3c7f0b2c5207a456d6221b290ea0473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abstract</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamidi, Oksana</creatorcontrib><creatorcontrib>Salama, Bahaa H</creatorcontrib><creatorcontrib>Dogra, Prerna</creatorcontrib><creatorcontrib>Dackiw, Alan P B</creatorcontrib><creatorcontrib>Nwariaku, Fiemu</creatorcontrib><creatorcontrib>Islam, Ana</creatorcontrib><creatorcontrib>Mehta, Ankeeta</creatorcontrib><creatorcontrib>Catherine Oltmann, Sarah</creatorcontrib><creatorcontrib>Mirfakhraee, Sasan</creatorcontrib><creatorcontrib>McKenzie, Travis</creatorcontrib><creatorcontrib>Foster, Trenton R</creatorcontrib><creatorcontrib>Lyden, Melanie</creatorcontrib><creatorcontrib>Dy, Benzon M</creatorcontrib><creatorcontrib>Bancos, Irina</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the Endocrine Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamidi, Oksana</au><au>Salama, Bahaa H</au><au>Dogra, Prerna</au><au>Dackiw, Alan P B</au><au>Nwariaku, Fiemu</au><au>Islam, Ana</au><au>Mehta, Ankeeta</au><au>Catherine Oltmann, Sarah</au><au>Mirfakhraee, Sasan</au><au>McKenzie, Travis</au><au>Foster, Trenton R</au><au>Lyden, Melanie</au><au>Dy, Benzon M</au><au>Bancos, Irina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>8219 Biochemical Disease Severity Score For Hypercortisolism Can Predict Adrenal Insufficiency After Adrenalectomy For Mild Autonomous Cortisol Secretion</atitle><jtitle>Journal of the Endocrine Society</jtitle><date>2024-10-05</date><risdate>2024</risdate><volume>8</volume><issue>Supplement_1</issue><issn>2472-1972</issn><eissn>2472-1972</eissn><abstract><![CDATA[Abstract
Disclosure: O. Hamidi: Advisory Board Member; Self; Corcept, Neurocrine Biosciences, Amryt Pharma, Recordati Rare Diseases, Lantheus, Xeris. B.H. Salama: None. P. Dogra: None. A.P. Dackiw: None. F. Nwariaku: None. A. Islam: None. A. Mehta: None. S.C. Oltmann: None. S. Mirfakhraee: None. T. McKenzie: None. T.R. Foster: None. M. Lyden: None. B.M. Dy: None. I. Bancos: None.
Introduction: Patients with mild autonomous cortisol secretion (MACS) are at risk for adrenal insufficiency (AI) after unilateral adrenalectomy. We aimed to determine the prevalence, predictors, and duration of AI after unilateral adrenalectomy for MACS, and to compare baseline and peak cortisol post cosyntropin stimulation test (CST) in diagnosing AI. Methods: We conducted a dual-center retrospective cohort study of patients with MACS who underwent unilateral adrenalectomy and were evaluated with postoperative cosyntropin stimulation test (CST). AI was diagnosed when postoperative morning cortisol was <10μg/dL and/or CST peak cortisol was <18μg/dL. Baseline and CST peak cortisol levels were considered concordant when both met corresponding cut-offs. Biochemical (BSS) and clinical (CSS) severity scores for hypercortisolism were calculated. Results: In 100 adults with MACS (77% women, median age 56 years, interquartile range [IQR] 48-63), median adenoma size was 2.8 cm (IQR, 2.2-3.7), and 25 (25%) had bilateral nodules. Median BSS was 3 (IQR, 2-5) and median CSS was 4 (IQR, 2-8). After adrenalectomy, AI was diagnosed in 56 (56%) patients. AI was associated with higher BSS, larger tumor size, but not age, sex, BMI, tumor laterality. Baseline and CST peak cortisol levels were concordant in 76% of cases. In 14% of cases morning cortisol was <10μg/dL but CST peak cortisol was ≥18μg/dL, and in 10% of cases morning cortisol was ≥10μg/dL, but CST peak cortisol was <18μg/dL. On a multivariable analysis that included age, sex, BMI, BSS, laterality, and tumor size, only higher BSS (odd ratio [OR] = 1.6 per 1 point) was associated with postoperative baseline cortisol <10μg/dL (P<0.05 for all). Independent predictors of CST peak cortisol <18μg/dL were BSS (OR 1.5 per 1 point) and unilateral adenoma (OR 3.7). During a median postoperative follow up of 13 months, 33 (59%) patients recovered from AI. Median time to recovery was 6.0 months, with AI recovery in 28% of patients by 2 months, 42% by 3 months, 53% by 6 months, and 64% by 12 months. Conclusions: Prevalence of postoperative AI in MACS was 56%. Only 76% of patients had concordant baseline and CST peak cortisol, with peak CST cortisol being more commonly abnormal in patients treated for unilateral MACS. Patients with larger adenomas and higher BSS were at higher risk for AI. Patients with MACS should be counseled about the risk and duration of AI after adrenalectomy.
Presentation: 6/3/2024]]></abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1210/jendso/bvae163.124</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2472-1972 |
| ispartof | Journal of the Endocrine Society, 2024-10, Vol.8 (Supplement_1) |
| issn | 2472-1972 2472-1972 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11454705 |
| source | DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Abstract |
| title | 8219 Biochemical Disease Severity Score For Hypercortisolism Can Predict Adrenal Insufficiency After Adrenalectomy For Mild Autonomous Cortisol Secretion |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T03%3A28%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=8219%20Biochemical%20Disease%20Severity%20Score%20For%20Hypercortisolism%20Can%20Predict%20Adrenal%20Insufficiency%20After%20Adrenalectomy%20For%20Mild%20Autonomous%20Cortisol%20Secretion&rft.jtitle=Journal%20of%20the%20Endocrine%20Society&rft.au=Hamidi,%20Oksana&rft.date=2024-10-05&rft.volume=8&rft.issue=Supplement_1&rft.issn=2472-1972&rft.eissn=2472-1972&rft_id=info:doi/10.1210/jendso/bvae163.124&rft_dat=%3Coup_pubme%3E10.1210/jendso/bvae163.124%3C/oup_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1210/jendso/bvae163.124&rfr_iscdi=true |